Atlas Trials

Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma.

Clinical trial NCT01073839 · COMPLETED

Trial details

NCT number
NCT01073839
Sponsor
University of Zurich
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cholangiocellular Carcinoma
Start date
2008-08-01
Primary completion
2015-08-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.